Amyloid-beta clearance in Alzheimer's disease
Strong evidence continues to accumulate indicating that amyloid-beta (Aß) is a central part of Alzheimer’s disease (AD) pathogenesis in spite of the negative evidence coming from failed clinical trials. Therefore, mechanisms of clearance of Aß are of great interest in understanding AD pathogenesis a...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Online |
| Dil: | İngilizce |
| Baskı/Yayın Bilgisi: |
Frontiers Media SA
2021
|
| Konular: | |
| Online Erişim: | 18589 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|